Cutting edge:: Myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus

被引:134
作者
Skerrett, SJ
Liggitt, HD
Hajjar, AM
Wilson, CB
机构
[1] Harborview Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98104 USA
[2] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA
[4] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA
关键词
D O I
10.4049/jimmunol.172.6.3377
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid differentiation factor 88 (MyD88) is an adapter molecule required for signal transduction via Toll-like receptors (TLRs) and receptors of the IL-1 family. Consequently, MyD88-deficient mice are highly susceptible to bacterial infections, including systemic infection with Staphylococcus aureus. To determine the role of MyD88 in innate immunity to bacterial pneumonia, we exposed MyD88-deficient and wild-type mice to aerosolized Pseudomonas aeruginosa or S. aureus. As predicted, MyD88-deficient mice failed to mount an early cytokine or inflammatory response or to control bacterial replication after infection with P. aeruginosa, which resulted in necrotizing pneumonia and death. By contrast, MyD88-deficient mice controlled S. aureus infection despite blunted local cytokine and inflammatory responses. Thus, whereas MyD88-dependent signaling is integral to the initiation of cytokine and inflammatory responses to both pathogens following infection of the lower respiratory tract, MyD88 is essential for innate immunity to P. aeruginosa but not S. aureus.
引用
收藏
页码:3377 / 3381
页数:5
相关论文
共 23 条
  • [1] Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
    Adachi, O
    Kawai, T
    Takeda, K
    Matsumoto, M
    Tsutsui, H
    Sakagami, M
    Nakanishi, K
    Akira, S
    [J]. IMMUNITY, 1998, 9 (01) : 143 - 150
  • [2] Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation
    Chamaillard, M
    Girardin, SE
    Viala, J
    Philpott, DJ
    [J]. CELLULAR MICROBIOLOGY, 2003, 5 (09) : 581 - 592
  • [3] PRETREATMENT WITH RECOMBINANT MURINE TUMOR NECROSIS FACTOR ALPHA-CACHECTIN AND MURINE INTERLEUKIN-1 ALPHA PROTECTS MICE FROM LETHAL BACTERIAL-INFECTION
    CROSS, AS
    SADOFF, JC
    KELLY, N
    BERNTON, E
    GEMSKI, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (06) : 2021 - 2027
  • [4] MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria:: No role for either in macrophage listericidal activity
    Edelson, BT
    Unanue, ER
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (07) : 3869 - 3875
  • [5] Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and toll-like receptor 4-deficient mice
    Haziot, A
    Hijiya, N
    Gangloff, SC
    Silver, J
    Goyert, SM
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (02) : 1075 - 1078
  • [6] MURINE PULMONARY ALVEOLAR MACROPHAGES - RATES OF BACTERIAL INGESTION, INACTIVATION, AND DESTRUCTION
    KIM, M
    GOLDSTEIN, E
    LEWIS, JP
    LIPPERT, W
    WARSHAUER, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1976, 133 (03) : 310 - 320
  • [7] Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model
    Lettinga, KD
    Florquin, S
    Speelman, P
    van Ketel, R
    van der Poll, T
    Verbon, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (04) : 570 - 573
  • [8] Macela A, 1996, FEMS IMMUNOL MED MIC, V13, P235, DOI 10.1111/j.1574-695X.1996.tb00243.x
  • [9] Points of control in inflammation
    Nathan, C
    [J]. NATURE, 2002, 420 (6917) : 846 - 852
  • [10] The Toll-IL-1 receptor adaptor family grows to five members
    O'Neill, LAJ
    Fitzgerald, KA
    Bowie, AG
    [J]. TRENDS IN IMMUNOLOGY, 2003, 24 (06) : 287 - 290